1. Dyah Purnamasari. Diagnosis dan Klasifikasi DM. Dalam : Buku Ajar Ilmu
Penyakit Dalam. Jilid I. Edisi V. Aru W Sudoyo, Bambang Setiyohadi, Idrus
Alwi, editors. Interna Publishing. Jakarta. Cetakan Pertama Nopember 2009.
Hal : 1880 –1883.
2. Suyono S. Patofisiologi diabetes melitus. Dalam: Penatalaksanaan DM terpadu
FKUI. Jakarta 1999; 14.
3. Suyono S. Kecenderungan peningkatan jumlah pasien diabetes.
Dalam:Penatalaksanaan Terpadu. Jakarta : BP FKUI. 1999; 14.
4. Waspadji S. Komplikasi Kronik Diabetes : Mekanisme terjadinya, Diagnosis,
dan Strategi Pengelolaan. Dalam : Buku Ajar Ilmu Penyakit Dalam. Jilid I.
Edisi V. Aru W Sudoyo, Bambang Setiyohadi, Idrus Alwi, editors. Interna
Publishing. Jakarta. Cetakan Pertama Nopember 2009. . Hal : 1922 – 1929.
5. PERKENI.Konsensus Pengelolaan dan Pencegahan DM. 2011.
6. McCord JM, Fridovich I (1988). "Superoxide dismutase: the first twenty years
(19681988)". Free Radic. Biol. Med. 5 (5–6): 363–9.
7. PDB 1VAR (http:/ / www. rcsb. org/ pdb/ explore/ explore. do?
structureId=1VAR); Borgstahl GE, Parge HE, Hickey MJ, Johnson MJ,
Boissinot M, Hallewell RA, Lepock JR, Cabelli DE, Tainer JA (April 1996).
"Human mitochondrial manganese superoxide dismutase polymorphic variant
Ile58Thr reduces activity by destabilizing the tetrameric interface".
Biochemistry 35 (14): 4287–97.doi:10.1021/bi951892w. PMID 8605177.
8. Mayasari O, Tandrasasmita, Wulan DD, Nailufar F, Sinambela J, Rubianto R,
et al. Glucose lowering effect of DLBS 3233 is mediated through
phosphorylation of tyrosine and upregulation of PPARγ and GLUT4
expression. International Journal of General Medicine. 2011 ; 4. Halaman :
345 – 357.
9. Nailufar F, Tandrasasmita OM, Tjandrawinata RR. DLBS3233 increases
glucose uptake by mediating upregulation of PPARγand PPARγ expression.
44
Biomedicine & Preventive Nutrition 1 (2011). Halaman : 71–78
10. Suastika K, Nugrahini NE, Tjandrawinata RR, Sraswati R, Dwipayanan P,
Junita A, Sulaiman SSD. DLBS 3233, bioactive extract of lagerstroemia
speciosa and cinnamomum burmanii, lowers blood glucose and improves lipid
profile in type 2 diabetes. Original research DLBS 3233 in type 2 diabetes.
Halaman : 1 – 20.
11. Tandrasasmita OM, Wulan DD, Nailufar F, Sinambela J, Tjandrawinata RR.
Glucoselowering effect of DLBS3233 is mediated through phosphorylation
of tyrosine and upregulation of PPARγ and GLUT4 expression. Int J Gen Med
2011; 4:345387.
12. Nailufar F, Tandrasasmita OM, Tjandrawinata RR. DLBS3233 increases
glucose uptake by mediating upregulation of PPARγ and PPARδ expression.
Biomed Prev Nutr (2011) doi:10.1016/j.bionut.2010.12.002
13. Nailufar F, Tjandrawinata RR. Effect of DLBS3233, an insulin sensitizer, on
fructoseinduced insulin resistance rat. Medicinus 2011; 24(1):1317
14. Wijaya, L., Hendri, P. Nofiarny, D., Tjandrawinata, R.R. Clinical Trial Phase
II of DLBS3233. Dexa Medica, Jakarta 2010. Data on file.
15. Sukandar EY, Sigit JI, Adnyana IK. Study of acute, subchronic toxicity and
teratogenicity of DLBS3233. Study report. Bandung Institute of Technology,
Bandung 2008
16. Karam JH, German MS. Pancreatic Hormone and Diabetes Mellitus. Dalam :
Greenspan FS, Gardner DG :Basic and clinical endocrinology. 7th ed. 2004.
Mc Graw Hill . New York. Halaman : 658 – 666.
17. Tjokroprawiro A. The Dietetic Regimen for Indonesian Patients with Diabetes
Mellitus. Surabaya ; 2014. Disitasi : Januari 14. Diambil dari :
http://www.dexamedica.com/sites/default/files/MEDICINUS
%202011%20Jul.pdf
45
18. Tandrasasmita MO, Wulan DD, Nailufar F,editors. Glucose
lowering effect of DLBS3233 is mediated through phosphorylation of tyrosine
and upregulation of PPARγ and GLUT4 expression. 2011. Disitasi 3 mei
2011. Diambil dari :
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108202/
19. Diabetes. Dexa Laboratories of Biomolecular Sciences . Disitasi tanggal 3 Mei
2014, Diambil dari : http://www.dlbs.co/http%3A/dev.ferron
pharma.com/ethical/inlacin
20. Wanasundara, F Shahidi 2005. Antioxidants: Science, Technology, and
Applications. Disitasi 5 Februaru 2013. Diunduh dari: http://uqu.edu.sa/files2/
tiny_mce/plugins/filemanager/files/4281709/84607_11.pdf
21. Barus, P. 2009. Pemanfaatan Bahan Pengawet dan Antioksidan Alami Pada
Industri Bahan Makanan.. Disitasi 5 Februari 2013. Diunduh dari:
http://www.usu.ac.id/id/files/pidato/pina.pdf.
22. Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: a
comparison of the CuZnSOD (SOD1), MnSOD (SOD2), and ECSOD
(SOD3) gene structures, evolution, and expression. Elsevier Science Inc. 2002
May; 33(2): 337349.
23. Cao X, et al. Structures of the G85R variant of SOD1 in familial amyotrophic
lateral sclerosis. J. Biol. Chem. 283 (23): 16169–77.
24. Borgstahl GE, Parge HE, et al. Human mitochondrial manganese superoxide
dismutase polymorphic variant Ile58Thr reduces activity by destabilizing the
tetrameric interface. Biochemistry 35 (14): 4287–97
25. Antonyuk SV, Strange RW, Marklund SL, Hasnain S. The structure of human
extracellular copperzinc superoxide dismutase at 1.7 A resolution: insights
into heparin and collagen binding". J. Mol. Biol. 388 (2): 310–26.
26. Gardner PR, Raineri I, Epstein LB, White CW. Superoxide radical and iron
modulate aconitase activity in mammalian cells. J. Biol. Chem.1995. 270 (22):
13399–405.
27. Dugani CB, Klip A. Glucose transporter 4: cycling, compartments and
controversies. EMBO reports. 2005 (12): 11371142.
46
28. McGraw LabDepartment of Biochemistry, Weill Medical College of Cornell
University. Insulinregulated movement of glut4. Disitasi 1 Juni 2014. Diakses
dari http://weill.cornell.edu/biochem/mcgraw/insulinregulated.html
29. Rihan B. The role of GLUT4 glucose transporter. Stanilaus Journal of
Biochemical. 2001 . Disitasi 27 Mei 2014 Diakses dari :
http://wwwchem.csustan.edu/chem4400/sjbr/Rihan01.htm
30. Widowati W. Potensi antioksidan sebagai antidiabetes. JKM. 2008 Februari;
7(2).
47